Table 1.
All Participants |
Participants With Serum Available |
|||||
---|---|---|---|---|---|---|
Characteristic | ACEi-Associated Angioedema (n=50) | ACEi-Exposed Control Subjects (n=176) | P | ACEi-Associated Angioedema (n=38) | ACEi-Exposed Control Subjects (n=170) | P |
Black:white, n | 20:30 | 88:88 | 0.21 | 13:25 | 87:83 | 0.06 |
Male:female, n | 24:26 | 85:91 | 0.97 | 16:22 | 83:87 | 0.45 |
Age, mean±SD, y | 58.6±14.4 | 58.0±11.1 | 0.78 | 59.7±14.7 | 58.0±11.1 | 0.52 |
Nonsmoker:smoker:unknown, n | 32:16:2 | 149:27:0 | 0.005 | 27:11 | 144:26 | 0.047 |
Nondiabetic:diabetic:unknown, n | 40:9:1 | 112:64:0 | 0.02 | 32:6 | 60:110 | 0.02 |
ACEi:off ACEi, n | 15:35 | 158:18 | <0.001 | 8:30 | 152:18 | <0.001 |